Substance P Receptor Antagonist 1 is a compound with potential therapeutic applications across various medical conditions. It demonstrates potential function in central nervous system disorders, such as depression, anxiety, and schizophrenia. Additionally, it shows promise in respiratory and inflammatory diseases like asthma and rheumatoid arthritis, as well as gastrointestinal disorders such as ulcerative colitis and Crohn's disease. This antagonist is also noted for its role in the transmission of pain, including migraine.
- Potential function in central nervous system disorders
- Potential function in respiratory and inflammatory diseases
- Potential function in gastrointestinal disorders
- Involved in the transmission of pain, including migraine
- Targets neurokinin receptor
- Pathway: GPCR/G protein; neuronal signaling